Ionis Pharmaceuticals | IONS - Cash And Equivalent


Ionis Pharmaceuticals reported $350.06M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Agios Pharmaceuticals USD 99.65M 13.95M Jun/2026
Alnylam Pharmaceuticals USD 1.71B 2.46M Jun/2026
Arrowhead Research USD 147.53M 54.11M Mar/2026
Astellas Pharma JPY 281.6B 93.23B Mar/2026
BioCryst Pharmaceuticals USD 154.97M 16.62M Jun/2026
BioMarin Pharmaceutical USD 874M 1.35B Jun/2026
Celltrion KRW 56.79B 6.92B Mar/2026
Cspc Pharmaceutical CNY 6.09B 1.48B Dec/2025
Deva Holding AS TRY 775.92M 574.67M Sep/2023
Divis Laboratories Ltd INR 1.28B 2.87B Mar/2026
Exelixis USD 226.15M 256.34M Mar/2026
Halozyme Therapeutics USD 163.14M 146.61M Jun/2026
Ionis Pharmaceuticals USD 350.06M 1.57B Jun/2026
Kangmei Pharma CNY 1.23B 48.16M Mar/2026
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Moderna USD 1.72B 185M Jun/2026
Nektar Therapeutics USD 149.58M 134.46M Mar/2026
Neuren Pharmaceuticals AUD 4.23M 1.68M Dec/2025
Neurocrine Biosciences USD 332.4M 65.9M Jun/2026
Novartis USD 7.62B 739M Jun/2026
Omeros USD 1.9M 2.36M Jun/2025
OPKO Health USD 341.88M 27.22M Mar/2026
Organigram Holdings CAD 4.29M 3.28M Mar/2026
Pfizer USD 976M 727M Jun/2026
Pharma Mar EUR 19.34M 29.53M Jun/2026
PTC Therapeutics USD 1.05B 215.9M Jun/2026
Qiagen NV USD 646.29M 192.72M Mar/2026
Regeneron Pharmaceuticals USD 2.46B 506.8M Jun/2026
Roche Holding CHF 7.55B 579M Jun/2025
Sarepta Therapeutics USD 571.15M 106.7M Jun/2026
Sartorius EUR 291M 282.8M Jun/2026
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Tilray USD 264.83M 43.16M Jun/2025
Ultragenyx Pharmaceutical USD 125M 50M Jun/2026
Vertex Pharmaceuticals USD 7.85B 605.7M Jun/2026
Zealand Pharma A/S 3.85B 727.54M Mar/2026
Zz Pientze Pharmaceu CNY 1.96B 186.63M Mar/2026